Drawing for ACTIVEZYME

USPTO serial 87583960

ACTIVEZYME

Reviewed by CopyMark Law Group

Reg. 5412971Status 702Registered
Filing date
Status date
Registration date
Feb 27, 2018
Examiner
REID, CAILE MAUREEN
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with ACTIVEZYME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph C. Andras

Joseph C. Andras Myers Andras Ashman Bisol LLP19800 MacArthur Blvd., Ste 1070Irvine, CA 92612United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical reagents, other than for medical or veterinary purposes, namely, a proprietary chemical reagent to be used as a conjugate stabilizer for Horseradish peroxidase (HRP)-based enzyme tracers, commonly incorporated in Immunoassay design or Immunohistology applicationACTIVEJun 24, 2002

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 19, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jan 19, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 19, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 27, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Feb 27, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 9, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 9, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 9, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 9, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 9, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 27, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 12, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 12, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 22, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 8, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 5, 2017ALIEASSIGNED TO LIE—
Oct 25, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 24, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Oct 24, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 24, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 24, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 24, 2017DOCKASSIGNED TO EXAMINER—
Aug 31, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 29, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance